BHL Vol. 18 Nr 5 Page 23

Bloedvaten, Hart, Longen

Vol 18

Nr 5

2013

for Thoracic Surgery, American College of Radiology,
American Stroke Association, Society of Cardiovascular
Anesthesiologists, Society for Cardiovascular Angiograp-
hy and Interventions, Society of Interventional Radiology,
Society of Thoracic Surgeons, and Society for Vascular
Medicine. Circulation 2010;121:e266-e369.

Tan JL, Davlouros PA, McCarthy KP, Gatzoulis MA, Ho SY.
Intrinsic histological abnormalities of aortic root and
ascending aorta in tetralogy of Fallot: evidence of cau-
sative mechanism for aortic dilatation and aortopathy.
Circulation 2005;112:961-8.

Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC
Guidelines for the management of grown-up conge-
nital heart disease (new version 2010). Eur Heart J
2010;31:2915-57.

Biner S, Rafique AM, Ray I, Cuk O, Siegel RJ, Tolstrup K.
Aortopathy is prevalent in relatives of bicuspid aortic
valve patients. J Am Coll Cardiol 2009;53:2288-95.

Huntington K, Hunter AG, Chan KL. A prospective study to
assess the frequency of familial clustering of congenital
bicuspid aortic valve. J Am Coll Cardiol 1997;30:1809-12.

Milewicz DM, Regalado E. Thoracic Aortic Aneurysms and
Aortic Dissections. 1993.

Pannu H, Fadulu VT, Chang J, et al. Mutations in transfor-
ming growth factor-beta receptor type II cause familial
thoracic aortic aneurysms and dissections. Circulation
2005;112:513-20.

Tran-Fadulu V, Pannu H, Kim DH, et al. Analysis of multi-
generational families with thoracic aortic aneurysms and
dissections due to TGFBR1 or TGFBR2 mutations. J Med
Genet 2009;46:607-13.

10.

Regalado ES, Guo DC, Villamizar C, et al. Exome sequen-
cing identifies SMAD3 mutations as a cause of familial
thoracic aortic aneurysm and dissection with intracranial
and other arterial aneurysms. Circ Res 2011;109:680-6.

11.

Lang RM, Bierig M, Devereux RB, et al. Recommendations
for chamber quantification: a report from the American
Society of Echocardiography's Guidelines and Standards
Committee and the Chamber Quantification Writing
Group, developed in conjunction with the European
Association of Echocardiography, a branch of the Eu-
ropean Society of Cardiology. J Am Soc Echocardiogr
2005;18:1440-63.

12.

Devereux RB, De Simone G, Arnett DK, et al. Normal
Limits in Relation to Age, Body Size and Gender of Two-
Dimensional Echocardiographic Aortic Root Dimensions
in Persons > /=15 Years of Age. Am J Cardiol 2012.

13.

Loeys BL, Dietz HC, Braverman AC, et al. The revised
Ghent nosology for the Marfan syndrome. J Med Genet
2010;47:476-85.

14.

Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dila-
tation and dissection in Turner syndrome. Circulation
2007;116:1663-70.

15.

Coady MA, Davies RR, Roberts M, et al. Familial patterns
of thoracic aortic aneurysms. Arch Surg 1999;134:361-7.

16.

Albornoz G, Coady MA, Roberts M, et al. Familial thoracic
aortic aneurysms and dissections--incidence, modes of
inheritance, and phenotypic patterns. Ann Thorac Surg
2006;82:1400-5.

17.

Westover AN, Nakonezny PA. Aortic dissection in
young adults who abuse amphetamines. Am Heart J
2010;160:315-21.

18.

Daniel JC, Huynh TT, Zhou W, et al. Acute aortic dis-
section associated with use of cocaine. J Vasc Surg
2007;46:427-33.

19.

Williams MA, Haskell WL, Ades PA, et al. Resistance
exercise in individuals with and without cardiovascular
disease: 2007 update: a scientific statement from the
American Heart Association Council on Clinical Car-
diology and Council on Nutrition, Physical Activity, and
Metabolism. Circulation 2007;116:572-84.

20.

Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1
antagonist, prevents aortic aneurysm in a mouse model
of Marfan syndrome. Science 2006;312:117-21.

21.

Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on
prevention of cardiovascular events in vascular Ehlers-
Danlos syndrome: a prospective randomised, open,
blinded-endpoints trial. Lancet 2010;376:1476-84.

22.

David TE, Feindel CM. An aortic valve-sparing operation
for patients with aortic incompetence and aneu-
rysm of the ascending aorta. J Thorac Cardiovasc Surg
1992;103:617-21.

23.

Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the
management of valvular heart disease (version 2012):
the Joint Task Force on the Management of Valvular
Heart Disease of the European Society of Cardiology
(ESC) and the European Association for Cardio-Thoracic
Surgery (EACTS). Eur J Cardiothorac Surg 2012;42:S1-44.

24.

Loeys BL, Chen J, Neptune ER, et al. A syndrome of
altered cardiovascular, craniofacial, neurocognitive and
skeletal development caused by mutations in TGFBR1 or
TGFBR2. Nat Genet 2005;37:275-81.

25.

Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndro-
mes caused by mutations in the TGF-beta receptor. N
Engl J Med 2006;355:788-98.

26.

Wang L, Guo DC, Cao J, et al. Mutations in myosin light
chain kinase cause familial aortic dissections. Am J Hum
Genet 2010;87:701-7.

27.

Renard M, Callewaert B, Baetens M, et al. Novel MYH11
and ACTA2 mutations reveal a role for enhanced TGFbeta
signaling in FTAAD. Int J Cardiol 2011.

28.

Khau Van Kien P, Wolf JE, Mathieu F, et al. Familial tho-
racic aortic aneurysm/dissection with patent ductus
arteriosus: genetic arguments for a particular pathophy-
siological entity. Eur J Hum Genet 2004;12:173-80.

29.

Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in
smooth muscle alpha-actin (ACTA2) cause coronary artery
disease, stroke, and Moyamoya disease, along with thora-
cic aortic disease. Am J Hum Genet 2009;84:617-27.

30.

Renard M, Callewaert B, Malfait F, et al. Thoracic aortic-aneury-
sm and dissection in association with significant mitral valve
disease caused by mutations in TGFB2. Int J Cardiol 2012.

31.

van de Laar IM, van der Linde D, Oei EH, et al. Phenotypic
spectrum of the SMAD3-related aneurysms-osteo-
arthritis syndrome. J Med Genet 2012;49:47-57.

32.

Judge DP, Dietz HC. Marfan's syndrome. Lancet
2005;366:1965-76.

33.

Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome
caused by a recurrent de novo missense mutation in the
fibrillin gene. Nature 1991;352:337-9.

34.

van de Laar IM, Oldenburg RA, Pals G, et al. Mutations in
SMAD3 cause a syndromic form of aortic aneurysms and
dissections with early-onset osteoarthritis. Nat Genet
2011;43:121-6.

35.

van der Linde D, van de Laar IM, Bertoli-Avella AM, et
al. Aggressive cardiovascular phenotype of aneurysms-
osteoarthritis syndrome caused by pathogenic SMAD3
variants. J Am Coll Cardiol 2012;60:397-403.

36.

Lindsay ME, Schepers D, Bolar NA, et al. Loss-of-function
mutations in TGFB2 cause a syndromic presentation of
thoracic aortic aneurysm. Nat Genet 2012;44:922-7.

37.

Schwarze U, Hata R, McKusick VA, et al. Rare autosomal
recessive cardiac valvular form of Ehlers-Danlos syn-
drome results from mutations in the COL1A2 gene that
activate the nonsense-mediated RNA decay pathway. Am
J Hum Genet 2004;74:917-30.

38.

Pepin M, Schwarze U, Superti-Furga A, Byers PH.
Clinical and genetic features of Ehlers-Danlos
syndrome type IV, the vascular type. N Engl J Med
2000;342:673-80.

39.

Malfait F, Symoens S, De Backer J., et al. Three arginine to
cysteine substitutions in the pro-alpha (I)-collagen chain
cause Ehlers-Danlos syndrome with a propensity to
arterial rupture in early adulthood. Hum Mutat
2007;28:387-95.

40.

Malfait F, Symoens S, Coucke P, Nunes L, De AS, De PA.
Total absence of the alpha2(I) chain of collagen type I
causes a rare form of Ehlers-Danlos syndrome with hy-
permobility and propensity to cardiac valvular problems.
J Med Genet 2006;43:e36.

41.

Coucke PJ, Willaert A, Wessels MW, et al. Mutations in the
facilitative glucose transporter GLUT10 alter angioge-
nesis and cause arterial tortuosity syndrome. Nat Genet
2006;38:452-7.

42.

Callewaert B, Renard M, Hucthagowder V, et al. New
insights into the pathogenesis of autosomal-dominant
cutis laxa with report of five ELN mutations. Hum Mutat
2011;32:445-55.

43.

Renard M, Holm T, Veith R, et al. Altered TGFbeta signa-
ling and cardiovascular manifestations in patients with
autosomal recessive cutis laxa type I caused by fibulin-4
deficiency. Eur J Hum Genet 2010;18:895-901.

44.

Morisaki H, Akutsu K, Ogino H, et al. Mutation of
ACTA2 gene as an important cause of familial and
nonfamilial nonsyndromatic thoracic aortic aneurysm
and/or dissection (TAAD). Hum Mutat 2009;30:
1406-11.

45.

Law C, Bunyan D, Castle B, et al. Clinical features in a
family with an R460H mutation in transforming growth
factor beta receptor 2 gene. J Med Genet 2006;43:908-16.

46.

Boileau C, Guo DC, Hanna N, et al. TGFB2 mutations
cause familial thoracic aortic aneurysms and dissections
associated with mild systemic features of Marfan syn-
drome. Nat Genet 2012;44:916-21.

47.

Kent KC, Crenshaw ML, Goh DL, Dietz HC. Genotype-
phenotype correlation in patients with bicuspid
aortic valve and aneurysm. J Thorac Cardiovasc Surg
2012.

48.

Zhu L, Vranckx R, Khau Van KP, et al. Mutations in myosin
heavy chain 11 cause a syndrome associating thoracic
aortic aneurysm/aortic dissection and patent ductus
arteriosus. Nat Genet 2006;38:343-9.

49.

Pannu H, Tran-Fadulu V, Papke CL, et al. MYH11 muta-
tions result in a distinct vascular pathology driven by
insulin-like growth factor 1 and angiotensin II. Hum Mol
Genet 2007;16:2453-62.